Hetterich Johannes, Pees Michael
Department of Small Mammal, Reptile and Avian Medicine and Surgery, University of Veterinary Medicine Hannover, Foundation, Hannover, Germany.
Front Vet Sci. 2025 May 21;12:1560689. doi: 10.3389/fvets.2025.1560689. eCollection 2025.
Fecal microbiota transplantation (FMT) is the process of transferring fecal microbiota from a healthy donor into the gastrointestinal tract of a recipient. Although many mechanisms of FMT are still not completely understood at present, it has been described that the treatment of various gastrointestinal diseases in different species, including humans, is significantly improved by FMT therapy. Since the first report on FMT therapy in veterinary medicine in small mammals numerous cases have been reported, but little information has been published on the therapeutic effects of FMT treatment in reptiles. The present case report describes the effects of orally administered fecal microbiota transplantation in a Mediterranean spur-thighed tortoise () suffering from chronic gastrointestinal disorders.
A nine-year-old, 330 g, intact female Mediterranean spur-thighed tortoise () from the animal owner's own offspring was presented for consultation due to decreased general condition, anorexia and sialorrhea following oral intake of a lettuce species () known for its poisonous plant ingredients (sesquiterpene lactones) 3 weeks prior to presentation. Pre-existing conditions were not reported. Clinical examination revealed sialorrhea and a reduced general condition. Diagnostic procedures included blood chemistry, radiography and ultrasonography. Despite repeated treatment attempts with various medical regimes over 158 days, the tortoise continued showing variable recurring gastrointestinal symptoms. An orally administered FMT was initiated and continued for a total of 3 weeks. Gastrointestinal signs improved rapidly within 1 week and resolved completely after 3 weeks. Over a follow up period of 9 months, no symptom recurrence or adverse effects were monitored.
This case report describes the first successful trial of fecal microbiota transplantation in chelonians. The outcome indicates that this therapeutic approach may be beneficial not only to small animals but also for the therapy of gastrointestinal disorders in reptiles, especially those cases with insufficient conventional therapy results.
粪便微生物群移植(FMT)是将健康供体的粪便微生物群转移到受体胃肠道的过程。尽管目前FMT的许多机制仍未完全了解,但已有描述表明,FMT疗法可显著改善包括人类在内的不同物种的各种胃肠道疾病的治疗效果。自首次报道小型哺乳动物兽医学中的FMT疗法以来,已有大量病例报道,但关于FMT治疗在爬行动物中的治疗效果的信息却鲜有发表。本病例报告描述了口服粪便微生物群移植对一只患有慢性胃肠道疾病的地中海陆龟()的影响。
一只9岁、体重330克、未绝育的雌性地中海陆龟(),来自动物主人自己的后代,因在就诊前3周口服了一种以其有毒植物成分(倍半萜内酯)而闻名的生菜品种()后,全身状况下降、厌食和流涎而前来咨询。未报告既往病史。临床检查发现流涎和全身状况下降。诊断程序包括血液化学、放射学和超声检查。尽管在158天内多次尝试使用各种医疗方案进行治疗,但这只陆龟仍持续出现反复的胃肠道症状。开始口服FMT并持续了3周。胃肠道症状在1周内迅速改善,并在3周后完全消失。在9个月的随访期内,未监测到症状复发或不良反应。
本病例报告描述了首次在龟类中成功进行粪便微生物群移植的试验。结果表明,这种治疗方法不仅可能对小型动物有益,而且对爬行动物胃肠道疾病的治疗也可能有益,尤其是那些传统治疗效果不佳的病例。